Institutional Ownership
Enanta Pharmaceuticals Inc
CUSIP 29251M106COMENTAQ1 2026
13D / 13G Filings
52
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
18.0%
Max % of class reported
Institutional Holders
128
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
52 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Deep Track Capital, LP | 13G/A | 6.8% | 1.96M | SEC |
| 2 | Feb 5, 2026 | Farallon Capital Partners, L.P. | 13G/A | 9.8% | 2.82M | SEC |
| 3 | Jan 20, 2026 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 670.4K | SEC |
| 4 | Nov 13, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 1.14M | SEC |
| 5 | Nov 7, 2025 | Janus Henderson Group PLC | 13G | 12.1% | 3.49M | SEC |
| 6 | Oct 9, 2025 | Deep Track Capital, LP | 13G | 5.3% | 1.48M | SEC |
| 7 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.8% | 1.67M | SEC |
| 8 | Feb 14, 2025 | Jay R. Luly, Ph.D. | 13D/A | 7.7% | — | SEC |
| 9 | Feb 11, 2025 | Farallon Capital Partners, L.P. | 13G/A | 9.9% | 2.11M | SEC |
| 10 | Jan 22, 2025 | Integrated Core Strategies (Us) LLC | 13G | 11.0% | 1.38M | SEC |
42 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Enanta Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 3.78M | $47.72M |
| 2 | Blackrock, Inc. | 3.10M | $39.20M |
| 3 | Farallon Capital Management LLC | 2.87M | $36.27M |
| 4 | Deep Track Capital, LP | 1.96M | $24.72M |
| 5 | Spruce Street Capital LP | 932.6K | $11.78M |
| 6 | Millennium Management LLC | 882.1K | $11.14M |
| 7 | Geode Capital Management, LLC | 725.1K | $9.16M |
| 8 | Renaissance Technologies LLC | 665.3K | $8.40M |
| 9 | State Street Corp | 562.1K | $7.10M |
| 10 | Hillsdale Investment Management Inc. | 435.5K | $5.50M |